These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2972670)

  • 21. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.
    Cremniter J; Slassi A; Quincampoix JC; Sivadon-Tardy V; Bauer T; Porcher R; Lortat-Jacob A; Piriou P; Judet T; Herrmann JL; Gaillard JL; Rottman M
    J Clin Microbiol; 2010 Apr; 48(4):1428-31. PubMed ID: 20164270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
    Low DE; McGeer A; Poon R
    Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
    Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
    Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin-resistant coagulase-negative staphylococci.
    Arioli V; Pallanza R
    Lancet; 1987 Jan; 1(8523):39. PubMed ID: 2879112
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    Biavasco F; Giovanetti E; Montanari MP; Lupidi R; Varaldo PE
    J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
    Jean-Pierre H; Rivière M; Darbas H; Boyer G
    Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients.
    Maugein J; Pellegrin JL; Brossard G; Fourche J; Leng B; Reiffers J
    Antimicrob Agents Chemother; 1990 May; 34(5):901-3. PubMed ID: 2141781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of in vitro activity of teicoplanin and vancomycin against coagulase negative methicillin resistant staphylococci isolated from high-risk patients.
    Battista C; Panza N; Chiurazzi B; Romano A; Pacilio G; Amato G; Gargiulo F; Bolletti Censi M; Bocchetti M
    Biomed Pharmacother; 1991; 45(1):43. PubMed ID: 1828377
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci.
    Felmingham D; Solomonides K; O'Hare MD; Wilson AP; Grüneberg RN
    J Antimicrob Chemother; 1987 Oct; 20(4):609-10. PubMed ID: 2960645
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
    Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
    Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
    Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
    J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
    Naylor PT; Myrvik QN; Gristina A
    Clin Orthop Relat Res; 1990 Dec; (261):126-33. PubMed ID: 2173986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of teicoplanin-resistant coagulase-negative staphylococci.
    Cercenado E; García-Leoni ME; Díaz MD; Sánchez-Carrillo C; Catalán P; De Quirós JC; Bouza E
    J Clin Microbiol; 1996 Jul; 34(7):1765-8. PubMed ID: 8784585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp.
    O'Hare MD; Reynolds PE
    J Antimicrob Chemother; 1992 Dec; 30(6):753-68. PubMed ID: 1289350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
    Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
    BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.